Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation

Leukemia and Lymphoma

Volumn 37, Issue 5-6, 2000, Pages 593-604

  Suzumiya, Junji ^a   Ohshima, Koichi ^a   Kanda, Motonobu ^a   Kumagawa, Midori ^a   Nagano, Mitsuyuki ^a   Hirata, Masayuki ^a   Nawa, Yukifumi ^b   Tamura, Kazuo ^a   Kikuchi, Masahiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Epstein Barr virus; Lymphohistiocytosis; Lymphoproliferative disorder; Malignant lymphoma; VAHS

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOKINE; DOXORUBICIN; ETOPOSIDE; GAMMA INTERFERON; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN J CHAIN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; VINCRISTINE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; VEP THP PROTOCOL; VEP-THP PROTOCOL;

ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; EPSTEIN BARR VIRUS; HEMOPHAGOCYTIC SYNDROME; HISTIOCYTOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; SOUTHERN BLOTTING; T LYMPHOCYTE; X CHROMOSOME LINKAGE; BRAIN TUMOR; CELL DIVISION; FATALITY; GENETICS; ISOLATION AND PURIFICATION; KARYOTYPING; LARGE CELL LYMPHOMA; LYMPHOCYTE ACTIVATION; PATHOGENICITY; PATHOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS CELL TRANSFORMATION; VIRUS INFECTION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; BLOTTING, SOUTHERN; BRAIN NEOPLASMS; CELL DIVISION; CELL TRANSFORMATION, VIRAL; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPSTEIN-BARR VIRUS INFECTIONS; ETOPOSIDE; FATAL OUTCOME; HERPESVIRUS 4, HUMAN; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IN SITU HYBRIDIZATION; INTERFERON TYPE II; INTERLEUKIN-10; KARYOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; POLYMERASE CHAIN REACTION; PREDNISOLONE; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; TUMOR VIRUS INFECTIONS; VINCRISTINE;

EID: 0034100232     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009058512     Document Type: Article

References (55)

1. Straus, S.E., Cohen, J.I., Tosato, G. and Meier, J. (1993). NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Annanls of Intern Medicene, 118, 45-58.
2. Ohshima, K., Suzumiya, J., Tasiro, K., Mukai, Y., Tanaka, T., Kato, A. and Kikuchi, M. (1996). Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese. American Journal of Hematology, 52, 21-28.
3. Nakanishi, M., Kikuta, H., Tomizawa, K., Kojima, K., Ishizaka, A., Okano, M., Sakiyama, Y. and Matsumoto, S. (1993). Distinct clonotypic Epstein-Barr virus-induced fatal lymphoproliferative disorder in a patient with Wiskott-Aldrich syndrome. Cancer, 72, 1376-1381.
4. Shapiro, R.S., McClain, K., Frizzera, G., Gajl Peczalska, K.J., Kersey, J.H., Blazar, B.R., Arthur, D.C., Patton, D.F., Greenberg, J.S., Burke, B, et al. (1988). Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood, 71, 1234-1243.
5. Hanto, D.W., Frizzera, G., Purtilo, D.T., Sakamoto, K., Sullivan, J.L., Saemundsen, A.K., Klein, G., Simmons, R.L. and Najarian, J.S. (1981). Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Research 41, 4253-4261.
6. Hanto, D.W., Birkenbach, M., Frizzera, G., Gajl Peczalska, K.J., Simmons, R.L. and Schubach, W.H. (1989). Confirmation of the heterogeneity of posttransplant Epstein-Barr virus-associated B cell proliferations by immunoglobulin gene rearrangement analyses. Transplantation, 47, 458-464.
7. Craig, F.E., Gulley, M.L., Banks, P.M., Thomason, R.W., Craig, F.E., Banks, P.M., Sears, D.L., Myerson, G.E. and Gulley, M.L. (1993). Posttransplantation lymphoproliferative disorders Epstein-Barr virus and lymphoproliferation in methotrexate-treated rheumatoid arthritis. American Journal of Clinical Pathology, 99, 265-276.
8. Cleary, M.L., Nalesnik, M.A., Shearer, W.T. and Sklar, J. (1988). Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood, 72, 349-352.
9. Lucas, K.G., Small, T.N., Heller, G., Dupont, B. and O'Reilly, R.J. (1996). The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood, 87, 2594-2603.
10. Carbone, A., Tirelli, U., Gloghini, A., Volpe, R. and Boiocchi, M. (1993). Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. Journal of Clinical Oncology, 11, 1674-1681.
11. Shibata, D., Weiss, L.M., Hernandez, A.M., Nathwani, B.N., Bernstein, L., Levine, A.M. and Levine, A.M. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood, 81, 2102-2109.
12. Knowles, D.M., Cesarman, E., Chadburn, A., Frizzera, G., Chen, J., Rose, E.A. and Michler, R.E. (1995). Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood, 85, 552-565.
13. Cline, M.J. (1994). Histiocytes and histiocytosis. Blood, 84, 2840-2853.
14. Kikuta, H., Sakiyama, Y., Matsumoto, S., Oh Ishi, T., Nakano, T., Nagashima, T., Oka, T., Hironaka, T. and Hirai, K. (1993). Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood, 82, 3259-3264.
15. Mroczek, E.C., Weisenburger, D.D., Grierson, H.L., Markin, R. and Purtilo, D.T. (1987). Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Archieve of Pathology and Laboratory Medicine, 111, 530-535.
16. Risdall, R.J., McKenna, R.W., Nesbit, M.E., Krivit, W., Balfour, H.H., Jr., Simmons, R.L. and Brunning, R.D. (1979). Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer, 44, 993-1002.
17. Sullivan, J.L., Woda, B.A., Herrod, H.G., Koh, G., Rivara, F.P. and Mulder, C. (1985). Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies. Blood, 65, 1097-1104.
18. Kawaguchi, H., Miyashita, T., Herbst, H., Niedobitek, G., Asada, M., Tsuchida, M., Hanada, R., Kinoshita, A., Sakurai, M., Kobayashi, N., et al. (1993). Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. Journal of Clinical Investigation, 92, 1444-1450.
19. Su, I.J., Chen, R.L., Lin, D.T., Lin, K.S. and Chen, C.C. (1994). Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. American Journal of Pathology, 144, 1219-1225.
20. Niedobitek, G., Hamilton Dutoit, S., Herbst, H., Finn, T., Vetner, M., Pallesen, G. and Stein, H. (1989). Identification of Epstein-Barr virus-infected cells in tonsils of acute infectious mononucleosis by in situ hybridization. Human Pathology, 20, 796-799.
21. Niedobitek, G., Herbst, H., Young, L.S., Brooks, L., Masucci, M.G., Crocker, J., Rickinson, A.B. and Stein, H. (1992). Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood, 79, 2520-2526.
22. Anagnostopoulos, I., Hummel, M., Kreschel, C. and Stein, H. (1995). Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the inter-individual infection route of Epstein-Barr virus. Blood, 85, 744-7450.
23. Laytragoon Lewin, N., Chen, F., Avila Carino, J., Klein, G. and Mellstedt, H. (1997). Epstein-Barr virus (EBV) gene expression in lymphoid B cells during acute infectious mononucleosis (IM) and clonality of the directly growing cell lines. International Journal of Cancer, 71, 345-349.
24. Fujiwara, F., Hibi, S. and Imashuku, S. (1993). Hypercytokinemia in hemophagocytic syndrome. American Journal of Pediatric Hematology and Oncolology, 15, 92-98.
25. Akashi, K., Hayashi, S., Gondo, H., Mizuno, S., Harada, M., Tamura, K., Yamasaki, K., Shibuya, T., Uike, N., Okamura, T., et al. (1994). Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. British Journal of Haematology, 87, 243-250.
26. Ohga, S., Matsuzaki, A., Nishizaki, M., Nagashima, T., Kai, T., Suda, M. and Ueda, K. (1993). Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity. American Journal of Pediatric Hematology and Oncology, 15, 291-298.
27. Osugi, Y. Hara, J., Tagawa, S., Takai, K., Hosoi, G., Matsuda, Y., Ohta, H., Fujisaki, H., Kobayashi, M., Sakata, N., Kawa Ha, K., Okada, S. and Tawa, A. (1997). Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood, 89, 4100-4103.
28. Randhawa, P.S., Demetris, A.J. and Nalesnik, M.A. (1994). The potential role of cytokines in the pathogenesis of Epstein-Barr virus associated post-transplant lymphoproliferative disease. Leukemia and Lymphoma, 15, 383-387.
29. Ohshima, K., Takeo, H., Kikuchi, M., Kozuru, M., Uike, N., Masuda, Y., Yoneda, S., Takeshita, M., Shibata, T. and Akamatsu, M. (1994). Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma. Histopathology, 25, 569-579.
30. Suzumiya, J., Takeshita, M., Kimura, N., Kikuchi, M., Uchida, T., Hisano, S., Eura, Y., Kozuru, M., Nomura, Y., Tomita, K., et al. (1994). Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood, 83, 2255-2260.
31. Weiss, L.M., Jaffe, E.S., Liu, X.F., Chen, Y.Y., Shibata, D. and Medeiros, L.J. (1992). Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood, 79, 1789-1795.
32. Saito, I., Servenius, B., Compton, T. and Fox, R.I. (1989). Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. Journal of Experimental Medicine, 169, 2191-2198.
33. Boyle, M.J., Vasak, E., Tschuchnigg, M., Turner, J.J., Sculley, T., Penny, R., Cooper, D.A., Tindall, B. and Sewell, W.A. (1993). Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise. Blood, 81, 468-474.
34. Chen, W.G., Chen, Y.Y., Bacchi, M.M., Bacchi, C.E., Alvarenga, M. and Weiss, L.M. (1996). Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene. American Journal of Pathology, 148, 17-23.
35. Suzumiya, J., Ohshima, K., Takeshita, M., Kanda, M., Kawasaki, C., Kimura, N., Tamura, K. and Kikuchi, M. (1999). Nasal lymphomas in Japan: A High Prevalence of Epstein-Barr Virus Type A and Deletion Within The Latent Membrane Protein Gene. Leukemia and Lymphoma (in press).
36. Knecht, H., Bachmann, E., Joske, D.J., Sahli, R., Emery Goodman, A., Casanova, J.L., Zilic, M., Bachmann, F. and Odermatt, B.F. (1993). Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease. Leukemia, 7, 580-585.
37. Karajannis, M.A., Hummel, M., Anagnostopoulos, I. and Stein, H. (1997). Strict lymphotropism of Epstein-Barr virus during acute infectious mononucleosis in nonimmunocompromised individuals. Blood, 89, 2856-2862.
38. Strickler, J.G., Movahed, L.A., Gajl Peczalska, K.J., Horwitz, C.A., Brunning, R.D. and Weiss, L.M. (1990). Oligoclonal T cell receptor gene rearrangements in blood lymphocytes of patients with acute Epstein-Barr virus-induced infectious mononucleosis. Journal of Clinical Investigation, 86, 1358-1363.
39. Henter, J.I., Elinder, G. and Ost, A. (1991). Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Seminar in Oncology, 18, 29-33.
40. Hanto, D.W., Frizzera, G., Gajl Peczalska, K.J., Sakamoto, K., Purtilo, D.T., Balfour, H.H., Jr., Simmons, R.L. and Najarian, J.S. (1982). Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. New England Journal of Medicine, 306, 913-918.
41. Grierson, H. and Purtilo, D.T. (1987). Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome. Annals of Internal Medicine, 106, 538-545.
42. Yatabe, Y., Mori, N., Oka, K., Iijima, T., Saga, S., Takada, K. and Asai, J. (1995). Fatal Epstein-Barr virus-associated lymphoproliferative disorder in childhood. Archieves of Pathology and Laboratory Medicine, 119, 409-417.
43. Oudejans, J.J., Jiwa, M., van den Brule, A.J., Grasser, F.A., Horstman, A., Vos, W., Kluin, P.M., van der Valk, P., Walboomers, J.M. and Meijer, C.J. (1995). Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. American Journal of Pathology, 147, 923-933.
44. Frank, D., Cesarman, E., Liu, Y.F., Michler, R.E. and Knowles, D.M. (1995). Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood, 85, 1396-1403.
45. Abruzzo, L.V., Schmidt, K., Weiss, L.M., Jaffe, E.S., Medeiros, L.J., Sander, C.A. and Raffeld, M. (1993). B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus. Blood, 82, 241-246.
46. Imashuku, S. (1997). Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. International Journal of Hematology, 66, 135-151.
47. Imashuku, S., Hibi, S., Fujiwara, F. Ikushima, S. and Todo, S. (1994). Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement. British Journal of Haematology, 88, 656-658.
48. Burke, G.W., Cirocco, R., Hensley, G., Reddy, R., Jeffers, L., Schiff, E. and Miller, J. (1992). The rapid development of a fatal, disseminated B cell lymphoma following liver transplantation-serial changes in levels of soluble serum interleukin 2 and interleukin 4 (B cell growth factor). Transplantation, 53, 1148-1150.
49. Baumann, M.A. and Paul, C.C. (1992). Interleukin-5 is an autocrine growth factor for Epstein-Barr virus-transformed B lymphocytes. Blood, 79, 1763-1767.
50. Tosato, G., Tanner, J., Jones, K.D., Revel, M. and Pike, S.E. (1990). Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. Journal of Virology, 64, 3033-3041.
51. Oyama, Y., Amano, T. Hirakawa, S., Hironaka, K., Suzuki, S. and Ota, Z. (1989). Haemophagocytic syndrome treated with cyclosporin A: a T cell disorder? British Journal of Haematology, 73, 276-278.
52. Sandvig, S., Laskay, T., Andersson, J., De Ley, M. and Andersson, U. Gamama-interferon is produced hy CD3+ and CD3-lymphocytes. Immunology Review, 97, 51-65.
53. Abed, N.S., Chace, J.H., Fleming, A.L. and Cowdery, J.S. (1994). Interferon-gamma regulation of B lymphocyte differentiation: activation of B cells is a prerequisite for IFN-gamma-mediated inhibition of B cell differentiation. Cellular Immunology, 153, 356-366.
54. Abed, N.S., Chace, J.H. and Cowdery, J.S. (1994). T cell-independent and T cell-dependent B cell activation increases IFN-gamma R expression and renders B cells sensitive to IFN-gamma-mediated inhibition. Journal of Immunology, 153, 3369-3377.
55. Bonnefoix, T., Gressin, R., Jacrot, M., Perron, P., Swiercz, P., Chaffanjon, P. and Sotto, J.J. (1997). Growth modulation of freshly isolated non-Hodgkin's B-lymphoma cells induced by various cytokines and all-trans-retinoic-acid. Leukemia and Lymphoma 25, 169-178.